OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $944.60 million. The enterprise value is $1.07 billion.
Important Dates
The last earnings date was Thursday, July 31, 2025, after market close.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 793.78 million shares outstanding. The number of shares has decreased by -4.63% in one year.
| Current Share Class | 793.78M |
| Shares Outstanding | 793.78M |
| Shares Change (YoY) | -4.63% |
| Shares Change (QoQ) | +17.34% |
| Owned by Insiders (%) | 43.98% |
| Owned by Institutions (%) | 25.82% |
| Float | 376.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.24 |
| Forward PS | 1.42 |
| PB Ratio | 0.72 |
| P/TBV Ratio | 15.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.31.
| Current Ratio | 3.41 |
| Quick Ratio | 2.21 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.28 |
Financial Efficiency
Return on equity (ROE) is -13.16% and return on invested capital (ROIC) is -9.96%.
| Return on Equity (ROE) | -13.16% |
| Return on Assets (ROA) | -8.46% |
| Return on Invested Capital (ROIC) | -9.96% |
| Return on Capital Employed (ROCE) | -14.85% |
| Revenue Per Employee | $221,565 |
| Profits Per Employee | -$59,105 |
| Employee Count | 2,997 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 8.97 |
Taxes
In the past 12 months, OPKO Health has paid $24.62 million in taxes.
| Income Tax | 24.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.20% in the last 52 weeks. The beta is 1.19, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -16.20% |
| 50-Day Moving Average | 1.34 |
| 200-Day Moving Average | 1.50 |
| Relative Strength Index (RSI) | 29.75 |
| Average Volume (20 Days) | 2,768,400 |
Short Selling Information
The latest short interest is 32.41 million, so 4.08% of the outstanding shares have been sold short.
| Short Interest | 32.41M |
| Short Previous Month | 34.14M |
| Short % of Shares Out | 4.08% |
| Short % of Float | 8.60% |
| Short Ratio (days to cover) | 9.60 |
Income Statement
In the last 12 months, OPKO Health had revenue of $664.03 million and -$177.14 million in losses. Loss per share was -$0.26.
| Revenue | 664.03M |
| Gross Profit | 96.43M |
| Operating Income | -267.56M |
| Pretax Income | -244.67M |
| Net Income | -177.14M |
| EBITDA | -172.85M |
| EBIT | -267.56M |
| Loss Per Share | -$0.26 |
Full Income StatementBalance Sheet
The company has $267.28 million in cash and $395.74 million in debt, giving a net cash position of -$128.46 million or -$0.16 per share.
| Cash & Cash Equivalents | 267.28M |
| Total Debt | 395.74M |
| Net Cash | -128.46M |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 1.30B |
| Book Value Per Share | 1.66 |
| Working Capital | 412.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$239.46 million and capital expenditures -$19.83 million, giving a free cash flow of -$259.29 million.
| Operating Cash Flow | -239.46M |
| Capital Expenditures | -19.83M |
| Free Cash Flow | -259.29M |
| FCF Per Share | -$0.33 |
Full Cash Flow StatementMargins
Gross margin is 14.52%, with operating and profit margins of -40.29% and -26.68%.
| Gross Margin | 14.52% |
| Operating Margin | -40.29% |
| Pretax Margin | -22.97% |
| Profit Margin | -26.68% |
| EBITDA Margin | -26.03% |
| EBIT Margin | -40.29% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.63% |
| Shareholder Yield | 4.63% |
| Earnings Yield | -18.75% |
| FCF Yield | -27.45% |
Dividend DetailsAnalyst Forecast
The average price target for OPKO Health is $2.75, which is 131.09% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.75 |
| Price Target Difference | 131.09% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 6.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.55 |
| Piotroski F-Score | 2 |
